After receiving a torrent of data about #semaglutide and newer #ObesityMedicines at #ADA2024, we're left wondering. Is semaglutide becoming old news or is it only now hitting its stride?
#ADASciSessions
https://conscienhealth.org/2024/06/semaglutide-at-ada2024-old-news-or-gaining-momentum/

At #ADA2024, it's plain that the top 3 problems for #ObesityCare are scale, scale, and scale. It stems from inequitable systems, exorbitant pricing, and Inadequate supply that sum to poor #AccessToCare.
#ADASciSessions
https://conscienhealth.org/2024/06/ada2024-where-is-the-problem-with-scale-for-obesity-care/

New data at #ADA2024 tells us that even low-dose, brief exposure to #BPA causes #InsulinResistance to rise. While many folks are busy demonizing food, BPA seems to get a pass from FDA.
#ADASciSessions
https://conscienhealth.org/2024/06/ada-2024-bpa-causes-insulin-resistance-why-do-we-drink-it/